CN103232528B - 一种生物活性多肽delq及其制备和应用 - Google Patents
一种生物活性多肽delq及其制备和应用 Download PDFInfo
- Publication number
- CN103232528B CN103232528B CN201210536557.8A CN201210536557A CN103232528B CN 103232528 B CN103232528 B CN 103232528B CN 201210536557 A CN201210536557 A CN 201210536557A CN 103232528 B CN103232528 B CN 103232528B
- Authority
- CN
- China
- Prior art keywords
- milk
- delq
- polypeptide
- biologically active
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 108
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 102
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title claims description 16
- 230000000975 bioactive effect Effects 0.000 title abstract description 4
- 235000013336 milk Nutrition 0.000 claims abstract description 36
- 239000008267 milk Substances 0.000 claims abstract description 36
- 210000004080 milk Anatomy 0.000 claims abstract description 36
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 28
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 17
- 230000002708 enhancing effect Effects 0.000 claims abstract description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 9
- 235000015140 cultured milk Nutrition 0.000 claims description 45
- 238000000855 fermentation Methods 0.000 claims description 23
- 230000004151 fermentation Effects 0.000 claims description 23
- 235000006708 antioxidants Nutrition 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 13
- 239000012634 fragment Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 11
- 230000003053 immunization Effects 0.000 claims description 10
- 238000000108 ultra-filtration Methods 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 230000003064 anti-oxidating effect Effects 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000002474 experimental method Methods 0.000 abstract description 28
- 238000000338 in vitro Methods 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 3
- 230000000242 pagocytic effect Effects 0.000 abstract description 3
- 235000013365 dairy product Nutrition 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 230000007969 cellular immunity Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 239000007788 liquid Substances 0.000 description 32
- 238000000034 method Methods 0.000 description 28
- 239000000523 sample Substances 0.000 description 28
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000000463 material Substances 0.000 description 17
- 239000000287 crude extract Substances 0.000 description 16
- 235000020183 skimmed milk Nutrition 0.000 description 12
- 210000000481 breast Anatomy 0.000 description 11
- 230000031700 light absorption Effects 0.000 description 11
- 210000004698 lymphocyte Anatomy 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 10
- 238000001819 mass spectrum Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 8
- 102000011632 Caseins Human genes 0.000 description 7
- 108010076119 Caseins Proteins 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 235000021247 β-casein Nutrition 0.000 description 7
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 6
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 6
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000003643 water by type Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000013068 control sample Substances 0.000 description 4
- 235000020247 cow milk Nutrition 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000467 phytic acid Substances 0.000 description 4
- 229940068041 phytic acid Drugs 0.000 description 4
- 235000002949 phytic acid Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000186866 Lactobacillus thermophilus Species 0.000 description 3
- 108010019160 Pancreatin Proteins 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 229940055695 pancreatin Drugs 0.000 description 3
- 210000003024 peritoneal macrophage Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 2
- 108010077544 Chromatin Proteins 0.000 description 2
- 240000002605 Lactobacillus helveticus Species 0.000 description 2
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000005030 aluminium foil Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940054346 lactobacillus helveticus Drugs 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- ZQOILFFBJUNGRA-NMVUUJPQSA-N (4s)-4-[[(2s)-2-amino-3-methylbutanoyl]amino]-5-[(2s)-2-[[(2s,3s)-1-[(2s)-2-[[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid Chemical group N([C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C ZQOILFFBJUNGRA-NMVUUJPQSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 108010022337 Leucine Enkephalin Proteins 0.000 description 1
- 101100001708 Mus musculus Angptl4 gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010093625 Opioid Peptides Proteins 0.000 description 1
- 102000001490 Opioid Peptides Human genes 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006315 carbonylation Effects 0.000 description 1
- 238000005810 carbonylation reaction Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- URLZCHNOLZSCCA-UHFFFAOYSA-N leu-enkephalin Chemical compound C=1C=C(O)C=CC=1CC(N)C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 URLZCHNOLZSCCA-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003399 opiate peptide Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229940032362 superoxide dismutase Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 108010030651 valyl-glutamyl-prolyl-isoleucyl-prolyl-tyrosine Proteins 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5424—Dairy protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
实验分组 | 刺激指数SI |
阴性对照组 | 1 |
DELQ | 1.154±0.376* |
Claims (9)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210536557.8A CN103232528B (zh) | 2012-12-12 | 2012-12-12 | 一种生物活性多肽delq及其制备和应用 |
US14/434,094 US20160200762A1 (en) | 2012-12-12 | 2013-12-12 | Bioactive polypeptide DELQ and preparation method as well as application thereof |
PCT/CN2013/089196 WO2014090172A1 (zh) | 2012-12-12 | 2013-12-12 | 一种生物活性多肽delq及其制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210536557.8A CN103232528B (zh) | 2012-12-12 | 2012-12-12 | 一种生物活性多肽delq及其制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103232528A CN103232528A (zh) | 2013-08-07 |
CN103232528B true CN103232528B (zh) | 2014-12-24 |
Family
ID=48880607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210536557.8A Active CN103232528B (zh) | 2012-12-12 | 2012-12-12 | 一种生物活性多肽delq及其制备和应用 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20160200762A1 (zh) |
CN (1) | CN103232528B (zh) |
WO (1) | WO2014090172A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103232528B (zh) * | 2012-12-12 | 2014-12-24 | 上海交通大学 | 一种生物活性多肽delq及其制备和应用 |
CN104546665A (zh) * | 2014-12-31 | 2015-04-29 | 王沥 | 瑞士乳杆菌ns-8发酵液的用途 |
CN105254743B (zh) * | 2015-10-16 | 2019-04-26 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽saep及其制备与应用 |
CN105254747B (zh) * | 2015-10-16 | 2019-02-05 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽yngvfqe及其制备与应用 |
CN105254748B (zh) * | 2015-10-16 | 2019-01-08 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽yellclnn及其制备与应用 |
CN105254739B (zh) * | 2015-10-16 | 2019-02-05 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽gtqytd及其制备与应用 |
CN105254750B (zh) * | 2015-10-16 | 2019-01-08 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽fgysgafkcl及其制备与应用 |
CN105254713B (zh) * | 2015-10-16 | 2019-01-08 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽 glpqevlne 及其制备与应用 |
CN105254749B (zh) * | 2015-10-16 | 2019-01-08 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽yvta及其制备与应用 |
CN105254751B (zh) * | 2015-10-16 | 2019-02-05 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽wnipmgliv及其制备与应用 |
CN105254740B (zh) * | 2015-10-16 | 2019-01-08 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽nqfyqkf及其制备与应用 |
CN105254741B (zh) * | 2015-10-16 | 2019-04-26 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽pihnsl及其制备与应用 |
CN105254738B (zh) * | 2015-10-16 | 2019-04-26 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽delqdkih及其制备与应用 |
CN105254742B (zh) * | 2015-10-16 | 2018-09-25 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽rlhsmkqgi及其制备与应用 |
CN107176995B (zh) * | 2017-07-06 | 2019-12-24 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽skvlpvpekavpypq及其制备方法和应用 |
CN107226857B (zh) * | 2017-07-06 | 2020-04-14 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽tiasgept及其制备方法和应用 |
CN113234783A (zh) * | 2021-04-16 | 2021-08-10 | 华南理工大学 | 一种鲍鱼多肽的制备方法及其应用 |
CN114315967B (zh) * | 2021-12-31 | 2023-07-25 | 宜肌坊(厦门)生物科技有限公司 | 一种抗氧化肽m8、其制备方法及应用 |
CN115252759A (zh) * | 2022-08-24 | 2022-11-01 | 四川大学华西第二医院 | 酸奶衍生多肽在制备延缓端粒缩短药物及抗衰老药物中的应用 |
CN116444649B (zh) * | 2022-11-30 | 2024-05-24 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽gitdplfkgm、gitdplfkg及其获得方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1557476A (zh) * | 2004-02-04 | 2004-12-29 | 高春平 | 具有多种生物活性的多肽营养剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69536000D1 (de) * | 1994-11-04 | 2009-10-22 | A2 Corp Ltd | Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte |
EP1098988B9 (en) * | 1998-07-21 | 2007-10-24 | Danisco A/S | Foodstuff |
JP4612270B2 (ja) * | 2002-06-27 | 2011-01-12 | 靖一 田沼 | 生理活性ペプチドの設計法及びその用途 |
CN103232528B (zh) * | 2012-12-12 | 2014-12-24 | 上海交通大学 | 一种生物活性多肽delq及其制备和应用 |
-
2012
- 2012-12-12 CN CN201210536557.8A patent/CN103232528B/zh active Active
-
2013
- 2013-12-12 US US14/434,094 patent/US20160200762A1/en not_active Abandoned
- 2013-12-12 WO PCT/CN2013/089196 patent/WO2014090172A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1557476A (zh) * | 2004-02-04 | 2004-12-29 | 高春平 | 具有多种生物活性的多肽营养剂 |
Non-Patent Citations (2)
Title |
---|
Characterization of oligo- and polypeptides isolated from yoghurt;Andreas schieber et al;《Eur food res technol》;20001231;第210卷;全文 * |
MHC class II DR classification based on antigen-binding groove natural selection;Shin-nosuke Takeshima et al;《Biochemical and biophysical research communications》;20090505(第385期);第138页表1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2014090172A1 (zh) | 2014-06-19 |
US20160200762A1 (en) | 2016-07-14 |
CN103232528A (zh) | 2013-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103232528B (zh) | 一种生物活性多肽delq及其制备和应用 | |
CN103232526B (zh) | 一种生物活性多肽lplp及其制备和应用 | |
CN102964427B (zh) | 一种生物活性多肽qepvl及其制备和应用 | |
CN105254750B (zh) | 一种生物活性多肽fgysgafkcl及其制备与应用 | |
CN104479001A (zh) | κ-酪蛋白来源生物活性肽的制备和应用 | |
CN104479002A (zh) | 牛乳β-酪蛋白来源生物活性肽的制备和应用 | |
CN104710524B (zh) | 牛乳αs2-酪蛋白来源生物活性肽的制备和应用 | |
CN107163136B (zh) | 一种生物活性多肽wnipmglivnq及其制备方法和应用 | |
CN107236031B (zh) | 一种生物活性多肽pmigvnqelay及其制备方法和应用 | |
CN105254740B (zh) | 一种生物活性多肽nqfyqkf及其制备与应用 | |
CN107200782B (zh) | 一种生物活性多肽vavvkkgsnfq及其制备方法和应用 | |
CN103012552B (zh) | 一种生物活性多肽qepv及其制备和应用 | |
CN105254751B (zh) | 一种生物活性多肽wnipmgliv及其制备与应用 | |
CN105254748B (zh) | 一种生物活性多肽yellclnn及其制备与应用 | |
CN105254713B (zh) | 一种生物活性多肽 glpqevlne 及其制备与应用 | |
CN105254738B (zh) | 一种生物活性多肽delqdkih及其制备与应用 | |
CN105254749B (zh) | 一种生物活性多肽yvta及其制备与应用 | |
CN105254739B (zh) | 一种生物活性多肽gtqytd及其制备与应用 | |
CN105254743B (zh) | 一种生物活性多肽saep及其制备与应用 | |
CN103232527B (zh) | 一种生物活性多肽slpq及其制备和应用 | |
CN105254747B (zh) | 一种生物活性多肽yngvfqe及其制备与应用 | |
CN105254742B (zh) | 一种生物活性多肽rlhsmkqgi及其制备与应用 | |
CN105254741B (zh) | 一种生物活性多肽pihnsl及其制备与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Shaohui Inventor after: Lu Panpan Inventor after: Sun Guanhua Inventor after: Ma Liuliao Inventor after: Zhou Jiehui Inventor after: Li Xian Inventor after: Zhan Dongsheng Inventor after: Gao Yang Inventor before: Zhang Shaohui Inventor before: Lu Panpan Inventor before: Sun Guanhua Inventor before: Ma Liuliao Inventor before: Zhou Jiehui Inventor before: Li Xian Inventor before: Zhan Dongsheng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG SHAOHUI LU SHANSHAN SUN GUANHUA MA LIU ZHOU JIEHUI LI XIAN ZHAN DONGSHENG TO: ZHANG SHAOHUI LU SHANSHAN SUN GUANHUA MA LIU ZHOU JIEHUI LI XIAN ZHAN DONGSHENG GAO YANG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 200240 Dongchuan Road, Shanghai, No. 800, No. Patentee after: SHANGHAI JIAO TONG University Patentee after: ZHEJIANG PANDA DAIRY CO. Address before: 200240 Dongchuan Road, Shanghai, No. 800, No. Patentee before: Shanghai Jiao Tong University Patentee before: ZHEJIANG PANDA DAIRY PRODUCTS Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20160810 Address after: Dong Cang Lu Ling Xi Cangnan County of Wenzhou City, Zhejiang province 325899 (panda Industrial Building 1 floor) Patentee after: ZHEJIANG HUITAI LIFE HEALTH TECHNOLOGY Co.,Ltd. Address before: 200240 Shanghai Minhang District Jinping road 558 Lane 105 Patentee before: Zhang Shaohui Effective date of registration: 20160810 Address after: 200240, No. 558, Lane 105, Jinping Road, Shanghai, Minhang District Patentee after: Zhang Shaohui Address before: 200240 Dongchuan Road, Shanghai, No. 800, No. Patentee before: Shanghai Jiao Tong University Patentee before: ZHEJIANG PANDA DAIRY CO. |